Articles tagged with Biodefenses
A landmark study by Macquarie University researchers shows that juvenile 'taster toads' can teach goannas to avoid eating poisonous cane toads, preventing population collapse. Goanna populations increased by up to 140% in areas where the 'taster toad' method was trialled.
Human activity on Hainan Island is causing changes in the body shapes and diets of tropical birds, resulting in biotic homogenisation. Despite efforts to protect biodiversity, the island's unique ecosystem is being affected by large-scale economic and land-use changes.
Colorado State University's Jean Peccoud leads a multi-institutional team analyzing the nation's biomanufacturing infrastructure security. The project aims to provide specific recommendations to strengthen biomanufacturing processes and ensure data integrity.
The Elsevier journal Vaccine has released a supplement dedicated to vaccines for biodefense, showcasing significant advancements in vaccine development against diverse human and veterinary pathogens. The publication acknowledges the shift from traditional military focus to protecting both civilian and military populations.
The Northeast Biodefense Center, a regional collaboration of major centers, will conduct interdisciplinary research on diagnostics, therapeutics, and vaccines to address emerging infectious diseases. The center has made significant contributions to global health, including the development of diagnostics for SARS and pandemic influenza.
The National Institute of Allergy and Infectious Diseases has renewed funding for the 11 Regional Centers of Excellence, with a total of $455 million over five years. The centers will focus on developing countermeasures against emerging infectious diseases.
Howard C. Berg, a pioneer in single molecule biology, has been awarded the Biophysical Society's Single Molecule Biophysics Award for his groundbreaking research on flagellated bacteria and fundamental cellular processes.
Botulinum toxins bind to neurons, disrupting communication and leading to paralysis. The new study provides a structural glimpse of how these toxins recognize receptors on human neurons, offering a promising target for designing drugs to block their action.
The University of Rochester Medical Center has received two new grants to fund research on preparing for a bioterrorist attack. The grants aim to develop mathematical models and computer simulations of the human immune system's response to influenza A and smallpox, two of the worst threats. Researchers will also focus on finding ways t...
The National Institute of Allergy and Infectious Diseases has awarded $60 million to support the development of new tularemia vaccines. This contract is part of a larger NIAID biodefense awards package, which includes funding for Regional Biocontainment Laboratories and research on high-priority pathogens such as anthrax and smallpox.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded new grants to strengthen the national biodefense and emerging infectious diseases research network. The grants support research on next-generation treatments, vaccines, and diagnostic tools for diseases such as anthrax, plague, smallpox, and West Nile fever.
The National Institute of Allergy and Infectious Diseases has awarded UC Irvine a $40 million grant to establish the Pacific-Southwest Center for Biodefense and Emerging Infectious Diseases Research. The center will focus on developing vaccines, antidotes, and new methods to prevent infectious diseases.
The Center for Biosecurity at UPMC analyzed US government civilian biodefense funding from 2001 to 2005, totaling $14.5 billion. The Department of Health and Human Services and the Department of Homeland Security together account for over 90% of budgeted funds.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded grants to fund the construction of six biosafety laboratories, including three NBLs and three RBLs. The new labs will provide a safe environment for scientists to conduct critical research on infectious diseases and bioterrorism.
The NIAID Biodefense Research Agenda has made significant strides in developing vaccines, treatments, and diagnostics for bioterror agents. The Institute has expanded partnerships with industry and academia to accelerate research and development of countermeasures.
The Emory-led consortium aims to study the entire range of human immune responses, from laboratory to clinic, to develop new vaccines addressing emerging infections and biothreats. Scientists will use genomics and proteomics to analyze vaccine-induced innate and adaptive immune responses.
The Virginia Bioinformatics Institute is at the forefront of a new regional center of excellence for biodefense and infectious disease research. This initiative aims to combat infectious diseases, including potential bioterrorism threats, by leveraging genomics, bioinformatics, and supercomputing capabilities.
The National Institute of Allergy and Infectious Diseases is launching a new program to support interdisciplinary research on infectious diseases, with eight regional centers expected to be established. The program aims to develop new therapies, vaccines, diagnostics, and tools to combat bioterrorism and emerging diseases.
The Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB) will develop new vaccines and diagnostics for orthopoxviruses, Bacillus anthracis, and Y. pestis. The consortium aims to address difficult problems in emerging infections with unprecedented speed.
Researchers have identified unique gene expression patterns in human cells after exposure to 8 different biothreat agents, enabling rapid detection of potentially exposed individuals. The study's findings offer possibilities for utilizing host gene expression responses for early illness prediction.
A Johns Hopkins study suggests that the public can effectively respond to bioterrorism attacks without panic. The researchers recommend providing timely accurate information and creating a constructive role for the public, who can adapt to situations based on available information.